COLO B Coloplast A/S Class B

Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.

Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.

Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded an AscenDrive agreement with Premier, Inc. AscenDrive is a national program designed to standardize the care delivery process and help drive the highest-level commitment and savings for members. Effective July 1, 2022, Coloplast is one of two suppliers awarded the AscenDrive contract for ostomy products. 

Premier is a leading healthcare improvement company uniting an alliance of approximately 4,400 U.S. hospitals and health systems and more than 225,000 other providers and organizations. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.  

“This agreement is an important milestone in our journey to establish full access in the U.S. for Coloplast, the world's No. 1 Ostomy brand. We are honored to have received this contract and look forward to working with Premier to provide products and services that create value for the AscenDrive membership,” said Manu Varma, Senior Vice President of Chronic Care North America. 

About Coloplast ostomy products 

Coloplast is dedicated to advancing the ostomy care industry. By continuously gathering feedback from clinicians and patients, Coloplast is able to innovate and solve daily problems for ostomy care. 

Coloplast also offers additional support through the Coloplast® Care program, which provides product and lifestyle advice, inspiration, and education resources for people living with an ostomy. 

About Coloplast 

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Visit for more information. 

Global press contact 

Peter Mønster, Senior Media Relations Manager 

 



   

U.S. press contact 

Kate Merwin, Head of Communications 

612-286-2455 

 

Attachment



EN
30/06/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch